Further, Oct-4 and Sox2 activate cancer stem cells or tumor-initiating cells in some contexts (Leis et al., 2012; Wuebben and Rizzino, 2017; Zhang et al., 2020; Robinson et al., 2021). The gene discussed is SOX2; the disease is neoplasm.